Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)Research in context

• Main Authors: Pascal Demoly (Author), Mathieu Molimard (Author), Jean-François Bergmann (Author), Bertrand Delaisi (Author), Amandine Gouverneur (Author), Jade Vadel (Author), Cédric Collin (Author), Laurence Girard (Author), Silvia Scurati (Author), Philippe Devillier (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: The only disease-modifying treatment currently available for allergic rhinitis (AR) is allergen immunotherapy (AIT). The main objective of the EfficAPSI real-world study (RWS) was to evaluate the impact of liquid sublingual immunotherapy (SLIT-liquid) on asthma onset and evoluti...